SUSQUEHANNA INTERNATIONAL GROUP, LLP - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 74 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q4 2021$226,000
-42.6%
170,930
-0.3%
0.00%
Q3 2021$394,000
-31.0%
171,430
+31.8%
0.00%
Q2 2021$571,000
-71.3%
130,073
-52.5%
0.00%
Q1 2021$1,988,000
-22.0%
273,747
-53.6%
0.00%
Q4 2020$2,548,000
+749.3%
589,728
+706.1%
0.00%
Q3 2020$300,00073,1580.00%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q4 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 6,449,856$8,514,0002.83%
RA Capital Management 9,694,789$12,797,0000.23%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$9,173,0000.19%
HARBOR CAPITAL ADVISORS, INC. 275,870$364,0000.13%
Artal Group S.A. 1,803,858$2,381,0000.06%
GSA CAPITAL PARTNERS LLP 338,756$447,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 1,335,174$1,762,0000.05%
PVG ASSET MANAGEMENT CORP 10,000$13,200,0000.05%
Anson Funds Management LP 348,266$460,0000.04%
Eversept Partners, LP 419,581$553,8470.04%
View complete list of ORCHARD THERAPEUTICS PLC shareholders